Invesco Ltd. Has $452,000 Position in OrthoPediatrics Corp. $KIDS

Invesco Ltd. raised its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.1% in the first quarter, HoldingsChannel.com reports. The fund owned 18,349 shares of the company’s stock after purchasing an additional 1,986 shares during the quarter. Invesco Ltd.’s holdings in OrthoPediatrics were worth $452,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Millennium Management LLC acquired a new stake in shares of OrthoPediatrics during the 4th quarter worth about $9,798,000. Point72 Asset Management L.P. acquired a new stake in shares of OrthoPediatrics during the 4th quarter worth about $7,450,000. Wellington Management Group LLP lifted its stake in shares of OrthoPediatrics by 20.2% during the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock worth $24,601,000 after buying an additional 178,078 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of OrthoPediatrics by 29.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after buying an additional 152,681 shares during the last quarter. Finally, Brown Advisory Inc. lifted its stake in shares of OrthoPediatrics by 6.2% during the 1st quarter. Brown Advisory Inc. now owns 1,628,747 shares of the company’s stock worth $40,116,000 after buying an additional 94,719 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Citigroup restated a “market outperform” rating on shares of OrthoPediatrics in a research note on Friday, August 8th. Wall Street Zen upgraded shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. JMP Securities set a $35.00 price objective on shares of OrthoPediatrics and gave the stock a “market outperform” rating in a research note on Friday, August 8th. Finally, BTIG Research dropped their price objective on shares of OrthoPediatrics from $40.00 to $39.00 and set a “buy” rating for the company in a research note on Wednesday, August 6th. Seven analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, OrthoPediatrics has a consensus rating of “Moderate Buy” and a consensus target price of $34.14.

OrthoPediatrics Price Performance

KIDS stock opened at $20.91 on Friday. The company has a quick ratio of 3.43, a current ratio of 6.66 and a debt-to-equity ratio of 0.27. OrthoPediatrics Corp. has a 12 month low of $16.59 and a 12 month high of $33.14. The firm has a market cap of $524.21 million, a P/E ratio of -11.68 and a beta of 1.06. The company’s 50-day moving average price is $21.09 and its two-hundred day moving average price is $22.00.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.06. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. The firm had revenue of $61.08 million for the quarter, compared to analyst estimates of $61.40 million. OrthoPediatrics has set its FY 2025 guidance at EPS. On average, analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Fred Hite purchased 5,076 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The shares were bought at an average cost of $19.41 per share, with a total value of $98,525.16. Following the acquisition, the chief financial officer owned 213,065 shares of the company’s stock, valued at $4,135,591.65. This trade represents a 2.44% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 32.70% of the company’s stock.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.